Author： Ajjan Ramzi A Grant Peter J
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.7, Iss.4, 2008-07, pp. : 367-376
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rosiglitazone: accusations over cardiovascular safety
Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. :
Access to resources
Recommend
By Wolffenbuttel B.H. Sels J-P. Huijberts M.S.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. :
By Barman Balfour J.A. Plosker G.L.
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :
The cardiovascular safety of tadalafil
By Reffelmann Thorsten Kieback Arne Kloner Robert A
Expert Opinion on Drug Safety, Vol. 7, Iss. 1, 2008-01 ,pp. :
Cardiovascular Safety of Sildenafil
Drug Safety, Vol. 26, Iss. 7, 2003-01 ,pp. :